Tdspharm Co., Ltd. (KOSDAQ:464280)

Tdspharm Statistics

Total Valuation

Tdspharm has a market cap or net worth of KRW 45.79 billion. The enterprise value is 33.29 billion.

Market Cap	45.79B
Enterprise Value	33.29B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Tdspharm has 5.53 million shares outstanding. The number of shares has increased by 14.26% in one year.

Current Share Class	5.53M
Shares Outstanding	5.53M
Shares Change (YoY)	+14.26%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	46.27%
Owned by Institutions (%)	4.27%
Float	2.95M

Valuation Ratios

The trailing PE ratio is 10.25.

PE Ratio	10.25
Forward PE	n/a
PS Ratio	1.66
PB Ratio	1.07
P/TBV Ratio	1.07
P/FCF Ratio	n/a
P/OCF Ratio	12.11
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.46, with an EV/FCF ratio of -3.66.

EV / Earnings	7.79
EV / Sales	1.21
EV / EBITDA	7.46
EV / EBIT	8.84
EV / FCF	-3.66

Financial Position

The company has a current ratio of 2.66, with a Debt / Equity ratio of 0.18.

Current Ratio	2.66
Quick Ratio	2.40
Debt / Equity	0.18
Debt / EBITDA	1.73
Debt / FCF	-0.85
Interest Coverage	16.90

Financial Efficiency

Return on equity (ROE) is 10.52% and return on invested capital (ROIC) is 13.56%.

Return on Equity (ROE)	10.52%
Return on Assets (ROA)	4.56%
Return on Invested Capital (ROIC)	13.56%
Return on Capital Employed (ROCE)	8.77%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.53
Inventory Turnover	7.00

Taxes

In the past 12 months, Tdspharm has paid 698.14 million in taxes.

Income Tax	698.14M
Effective Tax Rate	14.04%

Stock Price Statistics

The stock price has decreased by -24.66% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-24.66%
50-Day Moving Average	9,286.00
200-Day Moving Average	9,915.95
Relative Strength Index (RSI)	39.43
Average Volume (20 Days)	16,995

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Tdspharm had revenue of KRW 27.62 billion and earned 4.27 billion in profits. Earnings per share was 808.00.

Revenue	27.62B
Gross Profit	7.49B
Operating Income	3.77B
Pretax Income	4.97B
Net Income	4.27B
EBITDA	4.46B
EBIT	3.77B
Earnings Per Share (EPS)	808.00

Balance Sheet

The company has 20.21 billion in cash and 7.71 billion in debt, with a net cash position of 12.50 billion or 2,260.62 per share.

Cash & Cash Equivalents	20.21B
Total Debt	7.71B
Net Cash	12.50B
Net Cash Per Share	2,260.62
Equity (Book Value)	42.78B
Book Value Per Share	8,079.38
Working Capital	18.61B

Cash Flow

In the last 12 months, operating cash flow was 3.78 billion and capital expenditures -12.88 billion, giving a free cash flow of -9.10 billion.

Operating Cash Flow	3.78B
Capital Expenditures	-12.88B
Depreciation & Amortization	699.57M
Net Borrowing	730.82M
Free Cash Flow	-9.10B
FCF Per Share	-1,646.29

Margins

Gross margin is 27.11%, with operating and profit margins of 13.63% and 15.48%.

Gross Margin	27.11%
Operating Margin	13.63%
Pretax Margin	18.00%
Profit Margin	15.48%
EBITDA Margin	16.16%
EBIT Margin	13.63%
FCF Margin	n/a

Dividends & Yields

Tdspharm does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.26%
Shareholder Yield	-14.26%
Earnings Yield	9.34%
FCF Yield	-19.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Tdspharm has an Altman Z-Score of 5.35 and a Piotroski F-Score of 3.

Altman Z-Score	5.35
Piotroski F-Score	3